Loading patent…
AssigneeSignum Biosciences, Inc.
InventorsJeffry B. Stock, Maxwell Stock, Keshava Rapole, Seung-Yub Lee, Michael Voronkov, Eduardo Perez, Joel Gordon, Shuyi Chen, Jinglong Chen
Estimating the term…
Among other things, the present invention provides novel isoprenyl compounds capable of effectively modulating inflammatory responses and pharmaceutical, cosmetic, cosmeceutical and topical compositions comprising these isoprenyl compounds. Anti-inflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with inflammation. Proinflammatory compounds of the present invention are useful in treating or preventing diseases or conditions associated with suppression of inflammatory responses. Thus, the present invention also provides methods useful in the treatment or prevention of diseases or conditions associated with inflammation as well as methods useful in the treatment or prevention of diseases or conditions associated with suppression of inflammatory responses.
A method of treating a disease or condition in a subject, comprising administering to said subject the compound 4- (1-carboxy-2-((2E,6E)-3,7,11-trimethyldodeca-2.6.10-trienylthio)ethylamino)-4-oxobutanoic acid having the formula
A method of treating a skin disease or condition in a subject, comprising administering to said subject a pharmaceutical composition comprising the sodium salt of the compound 4-(1-carboxy-2-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienylthio)ethylamino)-4-oxobutanoic acid having the formula
Dependencies are inferred from the claim text.